Science Explorer Back to mapMap
Discussion
Topic · Public Health, Environmental and Occupational Health

Acute Lymphoblastic Leukemia research

Acute Lymphoblastic Leukemia research is a research topic within Public Health, Environmental and Occupational Health. Science Explorer counts 40k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, genetic basis, treatment, and outcomes of childhood acute lymphoblastic leukemia (ALL). It covers topics such as genetic alterations, minimal residual disease, pharmacogenomics, prognostic factors, and relapse risk. The papers also discuss the challenges and advancements in pediatric oncology for the treatment of childhood leukemia.

  • Childhood Cancer
  • Acute Lymphoblastic Leukemia
  • Genetic Alterations
  • Treatment Outcome
  • Minimal Residual Disease
  • Pharmacogenomics
  • Prognostic Factors
  • Thiopurine Therapy
  • Relapse Risk
  • Pediatric Oncology
Research works
40k
fractional, since 1950
In the world top 10%
4.1k
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+20%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Acute Lymphoblastic Leukemia research

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Acute Lymphoblastic Leukemia research research?

By volume, the United States and China publish the most (2.3k and 1k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.3k works
  2. 2 China 1k works
  3. 3 India 475 works
  4. 4 Brazil 382 works
  5. 5 Germany 274 works
  6. 6 Japan 266 works
  7. 7 Italy 262 works
  8. 8 United Kingdom 240 works
  9. 9 France 219 works
  10. 10 Canada 188 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 40.7%China: 18.0%India: 8.5%Brazil: 6.8%6 others listed: 25.9%41%largest
United States2,274 · 40.7%China1,006 · 18.0%India475 · 8.5%Brazil382 · 6.8%6 others listed1,448 · 25.9%

Shares of the rows listed above, not of the whole node.

Which institutions lead Acute Lymphoblastic Leukemia research research?

By volume in 2022-now, The University of Texas MD Anderson Cancer Center publishes the most Acute Lymphoblastic Leukemia research research, followed by Harvard University and St. Jude Children's Research Hospital.

By volume, 2022-now

  1. 1 The University of Texas MD Anderson Cancer CenterUnited States 141 works
  2. 2 Harvard UniversityUnited States 90 works
  3. 3 St. Jude Children's Research HospitalUnited States 75 works
  4. 4 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 64 works
  5. 5 Peking UniversityChina 55 works
  6. 6 All India Institute of Medical SciencesIndia 52 works
  7. 7 Soochow UniversityChina 47 works
  8. 8 University of Southern CaliforniaUnited States 46 works
  9. 9 Shanghai Jiao Tong UniversityChina 43 works
  10. 10 National Institutes of HealthUnited States 41 works

Who are the leading researchers in Acute Lymphoblastic Leukemia research?

The most-cited researchers publishing on Acute Lymphoblastic Leukemia research include David Moher, Ahmedin Jemal and Christopher J L Murray.

  1. 1 David Moher Canada 898k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Rebecca L. Siegel United States 582k citations
  5. 5 Freddie Bray France 550k citations
  6. 6 Jacques Ferlay France 486k citations
  7. 7 George Davey Smith United Kingdom 435k citations
  8. 8 Ali H. Mokdad United States 429k citations
  9. 9 Mark J. Daly United States 403k citations
  10. 10 Robert John Tibshirani United States 396k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Acute Lymphoblastic Leukemia research?

The most cited paper in Acute Lymphoblastic Leukemia research is "CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010" (Quinn T. Ostrom, Haley R Gittleman, P Farah et al., 2013), with 12,109 citations. Next come "Cancer treatment and survivorship statistics, 2016" (6,175) and "Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia" (5,818).

Most cited papers
#PaperReleasedCitations
1 CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2006-2010 Quinn T. Ostrom, Haley R Gittleman, P Farah et al. · Neuro-Oncology Open access 17 Oct 2013 12,109
2 Cancer treatment and survivorship statistics, 2016 Kimberly D. Miller, Rebecca L. Siegel, Chun Chieh Lin et al. · CA A Cancer Journal for Clinicians Open access 2 Jun 2016 6,175
3 Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia Shannon L. Maude et al. · New England Journal of Medicine Open access 31 Jan 2018 5,818
4 CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma Bertrand Coiffier, Éric Lepage, Josette Brière et al. · New England Journal of Medicine Open access 24 Jan 2002 5,630
5 Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia Shannon L. Maude, Noelle V. Frey, Pamela A. Shaw et al. · New England Journal of Medicine Open access 15 Oct 2014 5,489
All 100 most cited papers, with filters and sorting

Where is Acute Lymphoblastic Leukemia research research done?

The largest centres of Acute Lymphoblastic Leukemia research research in 2022-now are Houston (United States), Beijing (China), São Paulo (Brazil) and New York (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Duarte, Lancaster and Memphis.

Largest cities, 2022-now

  1. 1 HoustonUnited States 191 works
  2. 2 BeijingChina 182 works
  3. 3 São PauloBrazil 104 works
  4. 4 New YorkUnited States 96 works
  5. 5 ParisFrance 93 works
  6. 6 GuangzhouChina 89 works
  7. 7 MoscowRussia 88 works
  8. 8 BostonUnited States 87 works
  9. 9 LondonUnited Kingdom 87 works
  10. 10 MemphisUnited States 85 works

Where it is the local speciality

  1. DuarteUS · 20.2 works46×
  2. LancasterUS · 27.8 works45×
  3. MemphisUS · 85.2 works22×
  4. HoustonUS · 191.4 works9.9×
  5. TampaUS · 44.8 works8.3×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Acute Lymphoblastic Leukemia research than the world average.

See Acute Lymphoblastic Leukemia research on the map

Where is the best place to study Acute Lymphoblastic Leukemia research?

Among universities, judged by research, Harvard University, University of Southern California and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 15.1%fractional works in this field (log) →share of work in the world top 10% →Harvard UniversityStanford UniversityChinese Academy of M…University of Southe…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 89.019.3%4.1×90 +15.3%
2University of Southern CaliforniaUnited States 67.211.6%7.8×46 +25.4%
3Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 66.913.6%8.7×64 +62.9%
4Stanford UniversityUnited States 65.013.7%3.3×34 +10.7%
5University of WashingtonUnited States 64.519.9%3.2×25 +3.5%
6The Ohio State UniversityUnited States 64.115.1%4.2×36 +22.2%
7Baylor College of MedicineUnited States 63.713.0%10.8×38 +22.6%
8University College LondonUnited Kingdom 63.613.3%2.5×28 +22.5%
9Zhejiang UniversityChina 62.818.0%1.9×36 +62.2%
10University of TorontoCanada 62.413.5%2.8×40 +3.3%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Acute Lymphoblastic Leukemia research, country by country

Is Acute Lymphoblastic Leukemia research research growing?

Output in 2022-2025 was 20% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Acute Lymphoblastic Leukemia research.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Acute Lymphoblastic Leukemia research as a percentage of every work published that year, 0.031% in 2024.

still counting0.020%0.040%0.060%Acute Lymphoblastic Leukemia research0.035% in 202519801990200020102020

Fractional works of Acute Lymphoblastic Leukemia research over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Acute Lymphoblastic Leukemia research10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Acute Lymphoblastic Leukemia research. Posts are plain text and can be reported.